ANTI-PSEUDOMONAS ANTIBODIES AND LUNG DISEASE IN CYSTIC FIBROSIS

被引：0
|
作者：
Lu, S. [1 ]
Kolls, J. [1 ]
机构：
[1] Tulane Univ, New Orleans, LA 70118 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2021年 / 69卷 / 02期
关键词：
D O I：
10.1136/jim-2021-SRMC.44
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
44
引用
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [21] Ivacaftor Does Not Produce a Significant Change in Anti-Pseudomonas aeruginosa Antibodies
    Collins, A.
    Ronan, N. J.
    McCarthy, Y.
    Daly, M.
    Shortt, C.
    McCarthy, M.
    Fleming, C.
    Murphy, D. M.
    Plant, B. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S486 - S486
  • [22] Phenotypes That Matter: Pseudomonas aeruginosa and Progression of Cystic Fibrosis Lung Disease
    Sanders, Don B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (03) : 245 - 246
  • [23] A DOUBLE-BLIND CONTROLLED TRIAL OF ANTI-PSEUDOMONAS CHEMOTHERAPY OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS
    HYATT, AC
    CHIPPS, BE
    KUMOR, KM
    MELLITS, ED
    LIETMAN, PS
    ROSENSTEIN, BJ
    JOURNAL OF PEDIATRICS, 1981, 99 (02): : 307 - 311
  • [24] Anti-inflammatory cytokines in cystic fibrosis lung disease
    Starosta, V.
    Ratjen, F.
    Rietschel, E.
    Paul, K.
    Griese, M.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (03) : 581 - 587
  • [25] MUCOID PSEUDOMONAS AND THE CYSTIC-FIBROSIS LUNG
    RUSSELL, NJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (03) : 469 - 471
  • [26] Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis
    Lim, Sandy Z. P.
    Fitzgerald, Dominic A.
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 27 : 33 - 36
  • [27] Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
    Hoffman, Lucas R.
    Kulasekara, Hemantha D.
    Emerson, Julia
    Houston, Laura S.
    Burns, Jane L.
    Ramsey, Bonnie W.
    Miller, Samuel I.
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (01) : 66 - 70
  • [28] Age of Pseudomonas aeruginosa Acquisition and Subsequent Severity of Cystic Fibrosis Lung Disease
    Pittman, Jessica E.
    Calloway, Elizabeth H.
    Kiser, Michelle
    Yeatts, John
    Davis, Stephanie D.
    Drumm, Mitchell L.
    Schechter, Michael S.
    Leigh, Margaret W.
    Emond, Mary
    Van Rie, Annelies
    Knowles, Michael R.
    PEDIATRIC PULMONOLOGY, 2011, 46 (05) : 497 - 504
  • [29] Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
    Kosorok, MR
    Zeng, L
    West, SEH
    Rock, MJ
    Splaingard, ML
    Laxova, A
    Green, CG
    Collins, J
    Farrell, PM
    PEDIATRIC PULMONOLOGY, 2001, 32 (04) : 277 - 287
  • [30] Prospects for the next anti-Pseudomonas drug
    Page, Malcolm G. P.
    Heim, Jutta
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (05) : 558 - 565
12345